CNBC’s Jim Cramer delivers his daily Mad Dash.

July 7 (Reuters) - Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the U.S., adding to an activity rebound in the initial public offering ...

"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side ...

As the head of NIST, Raman will be charged with overseeing high-profile work in areas like artificial intelligence, quantum science and biotechnology.

Like tectonic plates colliding, humanism and the humanities are confronting movements that question long-held definitions of ...

New platform gives researchers access to the quantity and quality of antibody-antigen affinity and structural data required for next-generation protein engineering models.

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Nanoscope Therapeutics, a biotechnology company committed to commercializing novel, disease ...

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough ...